Is immunohistochemistry of BRAF V600E useful as a screening tool and during progression disease of melanoma patients?

被引：0
|
作者：
Laura Schirosi
Sabino Strippoli
Francesca Gaudio
Giusi Graziano
Ondina Popescu
Michele Guida
Giovanni Simone
Anita Mangia
机构：
[1] IRCCS Istituto Tumori “Giovanni Paolo II”,Functional Biomorphology Laboratory
[2] IRCCS Istituto Tumori “Giovanni Paolo II”,Medical Oncology Department
[3] IRCCS Istituto Tumori “Giovanni Paolo II”,Scientific Direction
[4] IRCCS Istituto Tumori “Giovanni Paolo II”,Pathology Department
来源：
BMC Cancer | / 16卷
关键词：
Melanoma; BRAF; VE1; Immunohistochemistry; Progression;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] BRAF V600E Immunohistochemistry in Cutaneous Langerhans Cell Histiocytosis
    Romano, R. C.
    Shon, W.
    Fritchie, K. L.
    LABORATORY INVESTIGATION, 2014, 94 : 142A - 142A
  • [22] BRAF V600E Immunohistochemistry in Cutaneous Langerhans Cell Histiocytosis
    Romano, R. C.
    Shon, W.
    Fritchie, K. L.
    MODERN PATHOLOGY, 2014, 27 : 142A - 142A
  • [23] Utility of BRAF V600E immunohistochemistry in the diagnosis of mandibular ameloblastomas
    Ji, Y. D.
    Johnson, D. N.
    Faquin, W. C.
    Peacock, Z. S.
    INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2024, 53 (02) : 122 - 126
  • [24] Potential Pitfalls in the Detection of BRAF V600E Mutation By Immunohistochemistry
    John, I. V. Y.
    Valente, Alfredo
    Tull, Jamie
    Maciak, Charlene
    Zhang, Shengle
    MODERN PATHOLOGY, 2015, 28 : 515A - 516A
  • [25] BRAF Mutation (V600E) Prevalence in Mexican Patients Diagnosed with Melanoma
    Denise Zepeda-Lopez, Priscilla
    Cesar Salas-Alanis, Julio
    Toussaint-Caire, Sonia
    Gutierrez-Mendoza, Daniela
    Vega-Memije, Elisa
    Lino Silva, Saul
    Raul Fajardo-Ramirez, Oscar
    Alcazar, Gregorio
    Guadalupe Moreno-Trevino, Mara
    Barrera Saldana, Hugo Alberto
    CASE REPORTS IN ONCOLOGY, 2016, 9 (01): : 241 - 245
  • [26] Dabrafenib in advanced melanoma with BRAF V600E mutation
    Abraham, Jame
    JOURNAL OF COMMUNITY AND SUPPORTIVE ONCOLOGY, 2014, 12 (02): : 48 - 49
  • [27] Vemurafenib in Melanoma with BRAF V600E Mutation REPLY
    Chapman, Paul B.
    Hauschild, Axel
    McArthur, Grant A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (15): : 1450 - 1450
  • [28] BRAF V600E and V600K in Melanoma: Clinicopathologic Correlation
    Purgina, B. M.
    Jelic, T.
    Chiosea, S. I.
    LABORATORY INVESTIGATION, 2012, 92 : 131A - 131A
  • [29] BRAF V600E and V600K in Melanoma: Clinicopathologic Correlation
    Purgina, B. M.
    Jelic, T.
    Chiosea, S. I.
    MODERN PATHOLOGY, 2012, 25 : 131A - 131A
  • [30] A screening test for BRAF mutant melanoma: Immunohistochemical (IHC) analysis of BRAF V600E mutation.
    Lyons, Tomas
    O'Brien, Odharnaith
    Murphy, Sandra
    Bambury, Richard
    O'Mahony, Deirdre
    O'Reilly, Seamus
    Heffron, Cynthia
    Power, Derek
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
12345